Patient care

NHS to roll-out new ‘triple combination’ therapy for hundreds of children and adults with cystic fibrosis

Hundreds of children and adults with rare forms of cystic fibrosis in England will be able to access “life-changing” new ‘triple-combination’ therapy for the very first time, the NHS has announced. Vanzacaftor–tezacaftor–deutivacaftor (Alyftrek®), is the latest in a new generation of therapies to be made available on the NHS that help treat the underlying cause […]

Read more

NHS England responds to ADHD Taskforce interim report

An independent taskforce set up to tackle challenges in attention deficit hyperactivity disorder (ADHD) care has published its interim report and recommendations today (Friday 20 June 2025). The report describes that the rates of recognised ADHD in England are lower than the expected prevalence and stresses the need for timely access to needs-based support. To […]

Read more

Millions receive help from NHS high street pharmacies

More than 5 million patients have received help from high street pharmacies for minor illnesses, as the NHS brings care closer to people’s homes.  Around 2.4 million people received help without booking an appointment at their local pharmacy for seven common conditions including sore throat, earache or shingles. Pharmacies delivered the most consultations for acute […]

Read more

NHS and local government to roll out world-first vaccine programme to prevent gonorrhoea

Thousands of gonorrhoea cases could be prevented over the next decade thanks to the NHS’ world-first vaccination programme against the infection. Eligible patients, which includes gay and bisexual men who have a recent history of multiple sexual partners or a sexually transmitted infection (STI), will start to be offered the vaccine through local authority-commissioned sexual […]

Read more

Thousands of NHS patients to benefit from ‘take at home’ multiple sclerosis tablet in European first

Thousands of NHS patients in England with multiple sclerosis (MS) are set to benefit from a life-changing ‘take at home’ tablet, as the NHS becomes the first healthcare system in Europe to roll it out widely to patients with active disease. The tablet, cladribine, requires just 20 days of treatment spread over four years, providing […]

Read more